Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

NFIC helps rat dental cells grow and turn into bone-like cells.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

NXC736 significantly reduced hair loss in mice with alopecia areata.

CRF can cause hair loss, but blocking its receptors might prevent this.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib may effectively treat folliculitis decalvans.

FLCN helps control iron levels in cells.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Lack of KSR1 stops certain skin tumors in mice.